MADISON, Wis. – The American Cancer Society Cancer Action Network (ACS CAN) has placed a billboard in Madison to thank Congress for demonstrating a strong commitment to cancer prevention and cures.
Michigan cancer survivors and American Cancer Society Cancer Action Network (ACS CAN) volunteers gathered with candidate Mike Rogers to discuss cancer in Michigan and policies that can reduce the cancer burden for everyone.
A new national poll commissioned by the American Cancer Society Cancer Action Network (ACS CAN) found that likely 2026 voters from both parties overwhelmingly support people having access to cancer screening and care, as well as support for the federal government continuing to invest in cancer research.
American Cancer Society Cancer Action Network Poll Shows Cancer is Top of Mind for Mainers This Election Season
ATLANTA – A recent poll by the American Cancer Society Cancer Action Network (ACS CAN) shows 85% of Georgia voters believe all Americans, regardless of the type of health insurance they have, should have access to affordable cancer screening and treatment close to home.
The FY26 appropriations bill included $47.2 billion for the National Institutes of Health, a $415 million increase over FY25 funding, and $7.352 billion for the National Cancer Institute, an increase of $128 million. Thanks in large part to the leadership of Oklahoma’s Rep. Tom Cole and Rep. Stephanie Bice as members of the powerful U.S. House Appropriations Committee. T
Last night, the Senate released the text of its continuing resolution to fund the federal government thru mid-December.
MONTGOMERY, Ala. – July 22, 2026 – The American Cancer Society Cancer Action Network (ACS CAN) has placed a billboard in Montgomery to thank Congress for demonstrating a strong commitment to cancer prevention and research in the latest appropriations bill.
Patient advocates and medical and public health leaders are renewing their call for an increased state investment in cancer research after the FY27 state budget maintained level funding for the New Jersey Commission on Cancer Research (NJCCR).